Freiburg im Breisgau, Germany - January 8, 2026 - Eleva, a pioneer in discovering and developing previously inaccessible biologics, today announced the appointment of Dr. Erich Rajkovic, MBA, as Chief ...
Eleva, a manufacturer of superior biologics, is scaling up its production capacity to 2500 l in state-of-the-art single-use reactors. This will produce enough factor H to cover all three clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results